Crispr Therapeutics shares tumble after significant earnings miss
Kratos Defense & Security Solutions (NASDAQ:KTOS) President of KTT Division, Stacey G. Rock, sold 4,000 shares of common stock on August 1, 2025, according to a Form 4 filing with the Securities and Exchange Commission. The sales, totaling $222,025, were executed at weighted average prices ranging from $55.1199 to $55.8053 per share.
Specifically, Rock sold 1,745 shares at a weighted average price of $55.1199, with individual prices ranging from $54.56 to $55.50. An additional 2,255 shares were sold at a weighted average price of $55.8053, with prices ranging from $55.555 to $56.26.
The transactions were executed under a pre-arranged 10b5-1 trading plan adopted on May 22, 2024. Following the sales, Rock directly owns 42,154 shares of Kratos Defense & Security Solutions. This includes 1,723 shares purchased through the company’s Employee Stock Purchase Plan and approximately 6,725 shares held through the company’s 401(k) Plan.
In other recent news, several analyst firms have adjusted their price targets for Kratos Defense & Security, reflecting optimism about the company’s future prospects. Truist Securities has increased its price target from $52 to $78, maintaining a Buy rating, due to potential opportunities in Kratos’s unmanned systems and hypersonic technologies. Similarly, Citizens JMP raised its price target to $70 from $40, citing a significant premium in valuation compared to its peers. Stifel also adjusted its target to $70 from $54, following a partnership announcement between Kratos and Airbus to supply a Valkyrie-based drone to the German Air Force. Cantor Fitzgerald, on the other hand, has maintained its price target at $60 with an Overweight rating, expressing confidence in the growth potential of Kratos’s X-58 drone program. These developments indicate a positive outlook from analysts, with emphasis on strategic partnerships and technological advancements.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.